WYN delivers systemic recovery directly through the oral mucosa — bypassing the GI tract entirely. For the hungover, the cramping, the depleted, and the compromised: when your stomach can't handle anything else, WYN still works.
One product. One pouch. Every recovery moment — from the morning after to mile 20 to hour 14 of a shift. WYN is not a supplement. It's a new delivery category.
"The $4B IV hydration industry exists because oral delivery fails when you're compromised. WYN delivers the same GI bypass — no needle, no nurse, no clinic, $0.47 instead of $200."
| Factor | IV Drip | WYN Pouch |
|---|---|---|
| Bypasses GI Tract | ✅ Yes | ✅ Yes |
| Needs a Needle | Yes | No |
| Needs a Nurse | Yes | No |
| Needs a Clinic | Yes | No |
| Cost | $150–$300/session | $0.47/pouch |
| Time | 30–60 min | Pop and go |
| Portable | No | Pocket-sized |
90% of IV hydration customers don't need an IV — they need fast electrolyte delivery that bypasses the gut. WYN gives them that for 0.2% of the cost.
Every year, thousands of athletes DNF (Did Not Finish) races and competitions. The causes are overwhelmingly problems WYN directly addresses:
| Reason | % of DNFs | WYN Addresses? |
|---|---|---|
| GI Distress (nausea, vomiting, diarrhea) | 30-40% | ✅ Directly — bypasses the gut entirely |
| Muscle Cramping / Electrolyte Depletion | 20-25% | ✅ Directly — delivers electrolytes buccally |
| Dehydration / Heat Illness | 15-20% | ✅ Directly — systemic electrolyte replenishment |
| Bonking / Energy Depletion | 10-15% | ⚡ Partially — B vitamins support energy metabolism |
| Musculoskeletal Injury | 10-15% | — Not addressed (different problem) |
The paradox: When athletes need electrolytes most — mid-race, mid-cramp, actively vomiting — their GI tract is the LEAST capable of absorbing them. Gels cause more nausea. Sports drinks slosh and churn. The stomach is offline.
WYN solves the paradox. Buccal absorption works regardless of GI state. The worse your stomach feels, the more you need WYN — and the more WYN outperforms every oral alternative.
WYN doesn't segment by demographic — it segments by moment of need. One SKU serves every human who has ever been dehydrated, depleted, or compromised.
| Metric | Value |
|---|---|
| COGS per pouch | $0.15–$0.25 |
| Retail price per can (15 pouches) | $6.99 |
| Revenue per pouch | $0.47 |
| Gross margin per can | ~65% |
| Wholesale price per can (to retailers) | $3.50–$4.00 |
| DTC margin (subscription) | ~75% |
| Metric | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Target Users | 5,000 | 25,000 | 100,000 |
| Cans/User/Month | 2 | 2.5 | 3 |
| Monthly Revenue | $70K | $437K | $2.1M |
| Annual Revenue | $838K | $5.2M | $25.2M |
| Gross Profit (65%) | $545K | $3.4M | $16.4M |
Recovery isn't a one-time event — it's a daily habit. WYN's subscription model ("WYN Direct") converts impulse buyers into predictable, high-margin recurring revenue.
| Tier | Contents | Price/Month | Savings vs. Retail |
|---|---|---|---|
| Starter | 2 cans (30 pouches) | $11.99 | 14% off |
| Daily Driver | 4 cans (60 pouches) | $21.99 | 21% off |
| All-In | 8 cans (120 pouches) | $39.99 | 28% off |
Subscription LTV is 3-5x higher than one-time purchase. Investors love MRR (Monthly Recurring Revenue).
DTC subscription = 75% margin vs. 40% through retail. No retailer taking 50% of the shelf price.
Auto-delivery builds WYN into the daily routine. Users don't "decide" to buy — it just arrives.
Direct relationship with every customer. Know exactly who buys, how often, and when they churn. Retail can't give you this.
Subscribers are first to try WYN+ Energy, WYN+ Nicotine. Built-in beta testing audience.
Retained subscribers reduce reliance on paid acquisition. Word-of-mouth from habitual users compounds.
Subscription revenue target: If 30% of WYN users convert to subscription at an average of $22/month, that's $1.98M ARR by Year 2 with 75% margins. By Year 3, subscription alone could drive $7.9M ARR — pure recurring, high-margin revenue that makes WYN fundable at Series A.
WYN Recovery is Phase 1 — the wedge into the market. WYN+ Nicotine is why this becomes a billion-dollar company.
| Factor | WYN Recovery (Non-Nicotine) | WYN+ Nicotine |
|---|---|---|
| Market Size | $10B recovery/hydration | $25B+ nicotine pouch market (growing 30%+ YoY) |
| Usage Frequency | Situational (2-4x/week) | Daily habit (5-10+ pouches/day) |
| Price per Can | $6.99 | $7.99–$8.99 |
| Cans/User/Month | 2-3 | 8-12 |
| Annual Revenue/User | $168–$252 | $768–$1,296 |
| Retention | Moderate (need-based) | Extremely high (nicotine = chemical dependency) |
| Regulatory Burden | Low (supplement) | High (FDA tobacco pathway) |
| Competitive Moat | First-mover in buccal recovery | Only recovery + nicotine pouch on market |
| WYN Recovery (Non-Nicotine) | WYN+ Nicotine (Phase 2) | |||||
|---|---|---|---|---|---|---|
| Metric | Y1 | Y2 | Y3 | Y1* | Y2 | Y3 |
| Users | 5K | 25K | 100K | — | 10K | 75K |
| Rev/User/Year | $168 | $210 | $252 | — | $960 | $1,080 |
| Annual Revenue | $838K | $5.2M | $25.2M | — | $9.6M | $81M |
| Combined Revenue | $838K | $14.8M | $106.2M | |||
*WYN+ Nicotine launches Year 2 after regulatory pathway secured
The strategy: WYN Recovery builds the brand, the distribution, the habit, and the trust. WYN+ Nicotine monetizes all of it at 4-5x the per-user revenue. Recovery is the vehicle. Nicotine is the destination. Every Zyn user who's ever been hungover or cramping is a WYN+ Nicotine customer waiting to switch.
Benchmark: Zyn did $2.4B in U.S. revenue in 2023. WYN needs just 1% of that behavioral audience — people who already pouch — to build a $25M+ business.
Target formulation per ~1g pouch. Starting spec for formulation scientist review.
| Ingredient | Form | Amount | % of Pouch | Function |
|---|---|---|---|---|
| Sodium | Sodium citrate | 100mg | 10% | Primary electrolyte. Citrate form gentle on mucosa. |
| Potassium | Potassium citrate | 75mg | 7.5% | Anti-cramping. Citrate form — less bitter, alkalizing. |
| Magnesium | Magnesium glycinate | 25mg | 2.5% | Muscle recovery. Glycinate absorbs well buccally. |
| DHM | Dihydromyricetin | 150mg | 15% | Hero ingredient. Accelerates alcohol metabolism. |
| Vitamin B1 | Thiamine | 5mg | 0.5% | Depleted by alcohol. Energy metabolism. |
| Vitamin B6 | Pyridoxine | 5mg | 0.5% | Anti-nausea, neurotransmitter support. |
| Vitamin B12 | Methylcobalamin | 50mcg | trace | Energy, neurological function. |
| Microencapsulation | Lipid/polymer shell | ~100mg | 10% | Controls release rate, prevents osmotic burn. |
| Pouch Matrix | Plant cellulose fiber | ~350mg | 35% | Structural base. Same matrix as Zyn. |
| Flavoring | Natural (mint/citrus) | ~100mg | 10% | Masks salt bitterness. |
| Sweetener | Stevia/Monk fruit | ~30mg | 3% | Zero sugar. Clean label. |
| Humectant | Glycerin | ~60mg | 6% | Moisture retention. Enables buccal absorption. |
Key formulation notes: All electrolytes in citrate/glycinate forms for optimal buccal tolerance and alkalizing effect. DHM at 150mg leverages higher buccal bioavailability (oral dose is typically 300mg). Microencapsulation is the make-or-break — controls release kinetics and prevents mucosal irritation. This is a starting spec for a formulation scientist to react to.
| Product | Delivery | GI Bypass | Portable | Cost | Recovery Stack |
|---|---|---|---|---|---|
| Liquid IV | Oral (drink) | ❌ | ⚠️ Needs water | $1.50/pkt | Electrolytes only |
| Pedialyte | Oral (drink) | ❌ | ⚠️ Bottle | $2.00/bottle | Electrolytes only |
| LMNT | Oral (drink) | ❌ | ⚠️ Needs water | $1.50/pkt | Electrolytes only |
| Gatorade | Oral (drink) | ❌ | ⚠️ Bottle | $2.00/bottle | Sugar + electrolytes |
| IV Drip (clinic) | Intravenous | ✅ | ❌ Clinic only | $150–$300 | Saline + vitamins |
| GU Gel | Oral (gel) | ❌ | ✅ | $1.50/pkt | Carbs + caffeine |
| WYN | Buccal (pouch) | ✅ | $0.47/pouch | Electrolytes + DHM + B Vitamins |
Zero direct competitors. No one else delivers recovery through the buccal membrane. WYN is a category of one.
Core product. Electrolytes + DHM + B Vitamins. One SKU, universal recovery. Supplement pathway (no FDA drug approval needed).
Add caffeine + L-theanine to the recovery stack. Targets pre-workout, shift workers, and daily energy users. Same supplement pathway.
The endgame. Recovery + nicotine in one pouch. Every Zyn user who's ever been hungover, cramping, or depleted switches to WYN+. 4-5x revenue per user. FDA tobacco pathway required.
Premium tier. Targeted stacks for specific use cases — endurance, altitude, clinical recovery. Partnerships with teams, military, medical.
| Category | Amount | % |
|---|---|---|
| Formulation & R&D (chemist, microencapsulation, iterations) | $75K | 30% |
| First Production Run (5,000–10,000 cans) | $62.5K | 25% |
| Marketing & Launch (campus ambassadors, sampling, social) | $62.5K | 25% |
| Operations & Legal (IP, compliance, ops setup) | $50K | 20% |
WYN is raising a $250K pre-seed round to bring the world's first buccal recovery pouch to market. If you're interested in category-creating consumer products with a clear path to $100M+ revenue, let's connect.
andres@wyn.com